64Cu-DOTA-M5A

N/A

Report date: 2025/09/24 14:01:38

Base Information

Drug Name64Cu-DOTA-M5A
Drug Alias Name64Cu-Labeled M5A AntibodyCopper Cu 64 Anti-CEA Monoclonal Antibody M5A64Cu labeled M5A antibodyCu 64-M5A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Copper > 64Cu +[4] 
Mechanisms of ActionAnti-CEA
TargetsCarcinoembryonic antigen
Therapy Area/IndicationsRectal NeoplasmsPeritoneal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesNational Cancer InstituteCity Of Hope National Medical Center
Inactive CompaniesN/A
Active IndicationsRectal NeoplasmsPeritoneal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A